Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE) and ...
Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...
The trial is conducted at the Mays Cancer Center, part of the University of Texas at San Antonio’s Health Science Center.
Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed ...
Heart disease remains the leading cause of death for women. Despite advancements in awareness and research, gaps remain in ...
Professor Lisa Volpatti developed a targeted approach that directs anti-inflammatory proteins to diseased arteries, reducing ...
Dr. Shune continues the case discussion by describing disease progression following second-line therapy and outlining her approach to third-line treatment selection in cGVHD. After initiating systemic ...
A team from UNIGE reveals how the 'hijacking' of neutrophils, a type of immune cell, promotes cancer growth and could provide insights into disease progression.
Scientists at The Wistar Institute have identified a previously overlooked mediator in the body's response to ...
Achieving 100 enrolled patients in the NIH-funded SEANOBI Expanded-Access Program marks substantial progress in the clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results